BDBM683055 US12023331, Example 1A

SMILES Fc1ccc(OCCCN2CC[C@H]3C(C2)c2cccc4NC(=O)CN3c24)cc1

InChI Key InChIKey=MXIJXDUPULMKIE-UHFFFAOYSA-N

Data  5 KI

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 5 hits for monomerid = 683055   

Target5-hydroxytryptamine receptor 2A(Human)
Intra-Cellular Therapies

US Patent
LigandPNGBDBM683055(US12023331, Example 1A)
Affinity DataKi:  10nMAssay Description:Receptor binding is determined for the Compound of Example 1, using the compound of Formula A as a control. The following literature procedures are u...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/8/2024
Entry Details
Go to US Patent

TargetSodium-dependent serotonin transporter(Human)
Intra-Cellular Therapies

US Patent
LigandPNGBDBM683055(US12023331, Example 1A)
Affinity DataKi:  16nMAssay Description:Receptor binding is determined for the Compound of Example 1, using the compound of Formula A as a control. The following literature procedures are u...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/8/2024
Entry Details
Go to US Patent

TargetD(1A) dopamine receptor(Human)
Intra-Cellular Therapies

US Patent
LigandPNGBDBM683055(US12023331, Example 1A)
Affinity DataKi:  41nMAssay Description:Receptor binding is determined for the Compound of Example 1, using the compound of Formula A as a control. The following literature procedures are u...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/8/2024
Entry Details
Go to US Patent

TargetD(2) dopamine receptor(Human)
Intra-Cellular Therapies

US Patent
LigandPNGBDBM683055(US12023331, Example 1A)
Affinity DataKi:  49nMAssay Description:Receptor binding is determined for the Compound of Example 1, using the compound of Formula A as a control. The following literature procedures are u...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/8/2024
Entry Details
Go to US Patent

TargetMu-type opioid receptor(Human)
Intra-Cellular Therapies

US Patent
LigandPNGBDBM683055(US12023331, Example 1A)
Affinity DataKi: >1.00E+4nMAssay Description:Receptor binding is determined for the Compound of Example 1, using the compound of Formula A as a control. The following literature procedures are u...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/8/2024
Entry Details
Go to US Patent